Rank | Ticker | Company | Weight | Country | Market Cap | Industry |
---|---|---|---|---|---|---|
1 | IMGN | ImmunoGen Inc | 5.01% | United States | $3.10b | Biotechnology |
2 | VKTX | Viking Therapeutics Inc | 4.94% | United States | $1.82b | Biotechnology |
3 | AGEN | Agenus Inc | 2.76% | United States | $432.83m | Biotechnology |
4 | TWST | Twist Bioscience Corp | 2.44% | United States | $742.62m | Diagnostics & Research |
5 | BPMC | Blueprint Medicines Corp | 2.02% | United States | $3.24b | Biotechnology |
6 | NVAX | Novavax Inc | 1.58% | United States | $639.41m | Biotechnology |
6 | NTRA | Natera Inc | 1.58% | United States | $5.62b | Diagnostics & Research |
8 | RVMD | Revolution Medicines Inc | 1.51% | United States | $2.69b | Biotechnology |
8 | PCVX | Vaxcyte Inc | 1.51% | United States | $3.89b | Biotechnology |
10 | ISEE | IVERIC bio Inc | 1.48% | United States | $5.11b | Biotechnology |
11 | KRTX | Karuna Therapeutics Inc | 1.47% | United States | $7.54b | Biotechnology |
12 | ARDX | Ardelyx Inc | 1.42% | United States | $751.63m | Biotechnology |
13 | RXDX | Prometheus Biosciences Inc | 1.39% | United States | $9.18b | Biotechnology |
14 | IOVA | Iovance Biotherapeutics Inc | 1.37% | United States | $1.67b | Biotechnology |
15 | CYTK | Cytokinetics Inc | 1.35% | United States | $3.58b | Biotechnology |
16 | VRTX | Vertex Pharmaceuticals Inc | 1.22% | United States | $87b | Biotechnology |
17 | CTIC | CTi Biopharma Corp | 1.21% | United States | $1.18b | Biotechnology |
18 | MRTX | Mirati Ther | 1.19% | United States | $2.60b | Biotechnology |
18 | IMVT | Immunovant Inc | 1.19% | United States | $2.77b | Biotechnology |
20 | RYTM | Rhythm Pharmaceuticals Inc | 1.18% | United States | $936.34m | Biotechnology |
20 | NBIX | Neurocrine Biosciences Inc | 1.18% | United States | $9.16b | Drug Manufacturers-Specialty & Generic |
20 | KRYS | Krystal Biotech Inc | 1.18% | United States | $2.25b | Biotechnology |
23 | SWTX | SpringWorks Therapeutics Inc | 1.16% | United States | $1.81b | Biotechnology |
24 | AMGN | Amgen Inc | 1.12% | United States | $120b | Drug Manufacturers-General |
25 | INSM | Insmed Inc | 1.1% | United States | $2.57b | Biotechnology |
26 | RNA | Avidity Biosciences Inc | 1.07% | United States | $756.94m | Biotechnology |
27 | SGEN | Seagen Inc | 1.06% | United States | $36b | Biotechnology |
28 | ADMA | ADMA Biologics Inc | 1.05% | United States | $892.45m | Biotechnology |
28 | CRSP | Crispr Therapeutics AG | 1.05% | United States | $4.99b | Biotechnology |
30 | CERE | Cerevel Therapeutics Holdings Inc | 1.04% | United States | $5.01b | Biotechnology |
30 | REGN | Regeneron Pharmaceuticals Inc | 1.04% | United States | $80b | Biotechnology |
32 | EXEL | Exelixis Inc | 1.01% | United States | $6.39b | Biotechnology |
33 | TGTX | TG Therapeutics Inc | 1% | United States | $4.48b | Biotechnology |
34 | UTHR | United Therapeutics Corporation | 0.95% | United States | $10.04b | Biotechnology |
35 | BBIO | BridgeBio Pharma Inc | 0.94% | United States | $2.24b | Biotechnology |
36 | IONS | Ionis Pharmaceuticals Inc | 0.92% | United States | $5.24b | Biotechnology |
37 | CPRX | Catalyst Pharmaceuticals Inc | 0.91% | United States | $1.27b | Biotechnology |
38 | KYMR | Kymera Therapeutics Inc | 0.88% | United States | $1.64b | Biotechnology |
38 | HALO | Halozyme Therapeutics Inc | 0.88% | United States | $4.51b | Biotechnology |
40 | ABBV | AbbVie Inc | 0.87% | United States | $254b | Drug Manufacturers-General |
41 | ACLX | Arcellx Inc | 0.86% | United States | $1.95b | Biotechnology |
42 | AGIO | Agios Pharm | 0.85% | United States | $1.43b | Biotechnology |
42 | RCUS | Arcus Biosciences Inc | 0.85% | United States | $1.29b | Biotechnology |
42 | RARE | Ultragenyx | 0.85% | United States | $3.58b | Biotechnology |
45 | HZNP | Horizon Pharma PLC | 0.84% | United States | $23b | Drug Manufacturers-General |
45 | GERN | Geron Corporation | 0.84% | United States | $1.34b | Biotechnology |
47 | VCYT | Veracyte Inc | 0.8% | United States | $1.77b | Biotechnology |
48 | CRNX | Crinetics Pharmaceuticals Inc | 0.76% | United States | $1.18b | Biotechnology |
48 | ARWR | Arrowhead Pharmaceuticals Inc | 0.76% | United States | $3.93b | Biotechnology |
50 | MRNA | Moderna Inc | 0.74% | United States | $48b | Biotechnology |